|
AREDS2 DNA Detail
|
|
|
| Records Return:
(53)
|
|
|
|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0795 | ED149267 | General Research Use | No | Male | White | 75 | 10 - Central GA | 10 - Central GA |
| AR2_1453 | ED149442 | General Research Use | No | Female | White | 69 | 10 - Central GA | 10 - Central GA |
| AR2_2357 | ED148560 | General Research Use | No | Female | White | 75 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2461 | ED149780 | General Research Use | No | Male | White | 82 | 10 - Central GA | 10 - Central GA |
| AR2_2799 | ED148768 | General Research Use | No | Female | White | 70 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2999 | ED148535 | General Research Use | No | Male | White | 81 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3395 | ED148551 | General Research Use | No | Female | White | 76 | 10 - Central GA | 10 - Central GA |
| AR2_3441 | ED148921 | General Research Use | No | Male | White | 63 | 10 - Central GA | 10 - Central GA |
| AR2_3906 | ED149613 | General Research Use | No | Male | White | 73 | 10 - Central GA | 10 - Central GA |
| AR2_3962 | ED148641 | General Research Use | No | Male | White | 77 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_4032 | ED149397 | General Research Use | No | Male | White | 66 | 10 - Central GA | 10 - Central GA |
| AR2_0165 | ED148635 | General Research Use | No | Male | White | 71 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0290 | ED148747 | General Research Use | No | Male | White | 78 | 10 - Central GA | 10 - Central GA |
| AR2_0513 | ED149636 | General Research Use | No | Female | White | 67 | 10 - Central GA | 10 - Central GA |
| AR2_0685 | ED149554 | General Research Use | No | Female | White | 68 | 10 - Central GA | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1195 | ED148252 | General Research Use | No | Female | White | 80 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1230 | ED148799 | General Research Use | No | Male | White | 75 | 10 - Central GA | 10 - Central GA |
| AR2_2069 | ED148728 | General Research Use | No | Male | White | 82 | 10 - Central GA | 10 - Central GA |
| AR2_2078 | ED148447 | General Research Use | No | Female | White | 68 | 10 - Central GA | 10 - Central GA |
| AR2_2125 | ED149845 | General Research Use | No | Female | White | 83 | 10 - Central GA | 10 - Central GA |
|
|
|
|